|
| 37333134 | Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179. | Res Sq | 2023 |
| 36976462 | Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. | Curr Oncol Rep | 2023 |
| 37467718 | A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence. | Cell Rep Med | 2023 |
| 36119496 | ErbB4 in the brain: Focus on high grade glioma. | Front Oncol | 2022 |
| 36497413 | Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? | Cancers (Basel) | 2022 |
| 36230692 | Potassium Ion Channels in Malignant Central Nervous System Cancers. | Cancers (Basel) | 2022 |
| 33472956 | Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma. | Sci Transl Med | 2021 |
| 37185327 | LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. | BMJ Open | 2021 |
| 33863878 | Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells. | Cell Death Discov | 2021 |
| 31504812 | Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore. | Neuro Oncol | 2020 |
| 31965010 | Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. | Sci Rep | 2020 |
| 31973233 | Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D Culture. | Cells | 2020 |
| 32804161 | A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies. | J Vis Exp | 2020 |
| 32168910 | MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells. | Cancers (Basel) | 2020 |
| 31002307 | Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma. | Neuro Oncol | 2019 |
| 32259073 | Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents. | ACS Pharmacol Transl Sci | 2019 |
| 31582283 | Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial. | J Clin Neurosci | 2019 |
| 31463571 | The dystroglycan receptor maintains glioma stem cells in the vascular niche. | Acta Neuropathol | 2019 |
| 30894629 | A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. | Sci Rep | 2019 |
| 29718345 | PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein. | Neuro Oncol | 2018 |
| 29944980 | Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors. | Pharmacol Res | 2018 |
| 29941341 | Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000⿯IU/L: Phase II Open Label, Single Arm Multi-Centre Trial. | EBioMedicine | 2018 |
| 30044378 | Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response. | Cancers (Basel) | 2018 |
| 29933129 | Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. | Transl Oncol | 2018 |
| 29574250 | A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors. | Neoplasia | 2018 |
| 28690875 | Combination of palbociclib and radiotherapy for glioblastoma. | Cell Death Discov | 2017 |
| 28435525 | Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent. | ACS Med Chem Lett | 2017 |
| 28501939 | Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma. | Cancer Immunol Immunother | 2017 |
| 28206758 | Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. | J Med Chem | 2017 |
| 28504693 | Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma. | Oncogenesis | 2017 |
| 26750997 | Incomplete target neutralization by the anti-cancer antibody rilotumumab. | MAbs | 2016 |
| 27822137 | Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma. | Sarcoma | 2016 |
| 27551537 | EGFRvIII: the promiscuous mutation. | Cell Death Discov | 2016 |
| 27551510 | Mitochondrial DNA plasticity is an essential inducer of tumorigenesis. | Cell Death Discov | 2016 |
| 24747966 | Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo. | Oncogene | 2015 |
| 26556723 | Targeted drug delivery using genetically engineered diatom biosilica. | Nat Commun | 2015 |
| 26416849 | Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity. | Hypertension | 2015 |
| 26519552 | Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling. | Biochem Pharmacol | 2015 |
| 27551460 | Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2. | Cell Death Discov | 2015 |
| 25659577 | EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications. | Oncogene | 2015 |
| 25719248 | Mitochondrial DNA copy number is regulated by DNA methylation and demethylation of POLGA in stem and cancer cells and their differentiated progeny. | Cell Death Dis | 2015 |
| 25806119 | Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines. | Anat Cell Biol | 2015 |
| 25795597 | DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications. | Pharmacol Ther | 2015 |
| 24068568 | The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma. | Tumour Biol | 2014 |
| 24995151 | Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma. | EJNMMI Res | 2014 |
| 24812320 | Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series. | Hum Reprod | 2014 |
| 24383468 | The identification of mitochondrial DNA variants in glioblastoma multiforme. | Acta Neuropathol Commun | 2014 |
| 23288908 | Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies. | Endocrinology | 2013 |
| 24084530 | Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy. | Obstet Gynecol | 2013 |
| 24084529 | Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth. | Obstet Gynecol | 2013 |